Difference between revisions of "Apligraf"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | <!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | ||
| − | Apligraf is a synthetic skin created from harvested foreskins.<ref>{{ | + | Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb |
| quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | | quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | ||
| + | | url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | ||
| + | | title=Apligraf: How Is It Made? | ||
| last= | | last= | ||
| first= | | first= | ||
| publisher=Organogenesis | | publisher=Organogenesis | ||
| − | | | + | | date= |
| − | |||
| − | |||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
| − | }}</ref> It is [[FDA]] approved,<ref>{{ | + | }}</ref> It is [[FDA]] approved,<ref>{{REFweb |
| quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | ||
| + | | url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | ||
| + | | title=Apligraf | ||
| last= | | last= | ||
| first= | | first= | ||
| publisher=Organogenesis | | publisher=Organogenesis | ||
| − | | | + | | date= |
| − | |||
| − | |||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. | }}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. | ||
Revision as of 15:54, 21 August 2019
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑
Apligraf: How Is It Made?
, Organogenesis. Retrieved 6 March 2011.
Quote:Human keratinocytes and fibroblasts are derived from neonatal foreskins
- ↑
Apligraf
, Organogenesis. Retrieved 6 March 2011.
Quote:Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
- ↑
(error)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.
